(Q39345457)

11 September 2017

CD44+/CD24- ovarian cancer cells demonstrate cancer stem cell properties and correlate to survival (English)

1 reference

11 September 2017

1 reference

neoplastic stem cells

1 reference

Erhong Meng

1

1 reference

11 September 2017

Beverely Long

2

1 reference

11 September 2017

Paula Sullivan

3

1 reference

11 September 2017

Steve McClellan

4

1 reference

11 September 2017

Michael A Finan

5

1 reference

11 September 2017

Eddie Reed

6

1 reference

11 September 2017

Lalita Shevde

7

1 reference

11 September 2017

Rodney P Rocconi

8

1 reference

11 September 2017

18 May 2012

1 reference

Clinical & Experimental Metastasis

11 September 2017

1 reference

11 September 2017

29

1 reference

11 September 2017

8

1 reference

11 September 2017

939-948

1 reference

https://scigraph.springernature.com/pub.10.1007/s10585-012-9482-4

11 September 2017

0 references

cites work

Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9482-4

Tumour stem cells and drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9482-4

ABCB5-mediated doxorubicin transport and chemoresistance in human malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9482-4

Stem cells, cancer, and cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9482-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9482-4

Therapeutic implications of cancer stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9482-4

Self-renewal and solid tumor stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9482-4

Frequency of cells expressing CD44, a head and neck cancer stem cell marker: correlation with tumor aggressiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9482-4

MicroRNA-200a inhibits CD133/1+ ovarian cancer stem cells migration and invasion by targeting E-cadherin repressor ZEB2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9482-4

Elevated invasive potential of glioblastoma stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9482-4

Ovarian cancer cells with the CD117 phenotype are highly tumorigenic and are related to chemotherapy outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9482-4

Downregulation of CD44 reduces doxorubicin resistance of CD44CD24 breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9482-4

Prospective identification of tumorigenic breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9482-4

CD44+/CD24- cells and lymph node metastasis in stage I and II invasive ductal carcinoma of the breast.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9482-4

Notch1 inhibition alters the CD44hi/CD24lo population and reduces the formation of brain metastases from breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9482-4

Stem cells: their role in breast cancer development and resistance to treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9482-4

An increase in cancer stem cell population after primary systemic therapy is a poor prognostic factor in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9482-4

Molecular phenotyping of human ovarian cancer stem cells unravels the mechanisms for repair and chemoresistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9482-4

Identification of cancer stem cell-like cells from human epithelial ovarian carcinoma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9482-4

Osteopontin knockdown suppresses tumorigenicity of human metastatic breast carcinoma, MDA-MB-435

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9482-4

Clinical implications of stem cell gene Oct-4 expression in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9482-4

Cell fate determination factor Dachshund reprograms breast cancer stem cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9482-4

Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9482-4

Normal stem cells and cancer stem cells: the niche matters

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9482-4

FoxO3a functions as a key integrator of cellular signals that control glioblastoma stem-like cell differentiation and tumorigenicity.

21 January 2018

1 reference

PubMed

12 December 2020

1 reference

12 December 2020

Hedgehog signaling pathway regulates the growth of ovarian cancer spheroid forming cells

1 reference

PubMed

12 December 2020

Adipose-derived stem cells promote gastric cancer cell growth, migration and invasion through SDF-1/CXCR4 axis

1 reference

PubMed

12 December 2020

10.1007/S10585-012-9482-4

Identifiers

DOI

1 reference

11 September 2017

1 reference